Zimmer Biomet Holdings (XSWX:ZBH) YoY EPS Growth: 31.47% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
68 GF Score
Price CHF81.00
GF Value CHF101.53
! 2 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings YoY EPS Growth?

Zimmer Biomet Holdings XSWX:ZBH 68 YoY EPS Growth is 31.47% as of Jun. 2026. GuruFocus rates XSWX:ZBH with a GF Score™ of 68/100 and a GF Value™ of CHF101.53. The stock has 2 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Zimmer Biomet Holdings's YoY EPS Growth for the quarter that ended in Jun. 2026 was 31.47%.

Zimmer Biomet Holdings's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was CHF0.82.

Zimmer Biomet Holdings YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Zimmer Biomet Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings YoY EPS Growth Chart

Zimmer Biomet Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 395.63 -41.73 311.71 -6.40 -28.38

Zimmer Biomet Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -40.66 -11.42 -47.10 19.53 31.47
XSWX:ZBH
68GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zimmer Biomet Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Zimmer Biomet Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EPS Growth (A: Dec. 2025 )
=(Earnings per Share (Diluted) (A: Dec. 2025 )-Earnings per Share (Diluted) (A: Dec. 2024 ))/ | Earnings per Share (Diluted) (A: Dec. 2024 ) |
=(2.829-3.95)/ | 3.95 |
=-28.38 %

Zimmer Biomet Holdings's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(0.823-0.626)/ | 0.626 |
=31.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 31.47% mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a YoY EPS Growth of 31.47% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Zimmer Biomet Holdings and its competitors.
Is Zimmer Biomet Holdings' YoY EPS Growth too high?
Zimmer Biomet Holdings' current YoY EPS Growth is 31.47%. Overall, Zimmer Biomet Holdings has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' YoY EPS Growth compare to STE and PEN?
Zimmer Biomet Holdings' YoY EPS Growth of 31.47% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Medical Devices & Instruments company?
A good YoY EPS Growth depends on the Medical Devices & Instruments industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current YoY EPS Growth is 31.47%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current YoY EPS Growth of 31.47%. The stock's GF Value™ is CHF101.53, compared to a current price of CHF81.00 — trading 20.2% below its estimated fair value. The current YoY EPS Growth is 31.47%. Zimmer Biomet Holdings' overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current YoY EPS Growth is 31.47% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF81.00 is trading 20.2% below its estimated GF Value™ of CHF101.53.

Key valuation signals for XSWX:ZBH:

  • YoY EPS Growth: 31.47%
  • GF Value™: CHF101.53 vs. price of CHF81.00 (20.2% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
68GF Score

Get the complete analysis for XSWX:ZBH

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF81.00
Price
CHF101.53
GF Value